Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma

    • Cancer
    • Non Hodgkin Lymphoma (NHL)
    • B-cell Non-Hodgkin Lymphoma